MedTrace Logo

The Remote Monitoring of Gout Feasibility Study in Primary Care

NCT07490522 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-30

No results posted yet for this study

Summary

The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are:

1. To determine the feasibility of a patient self-management app for patients with gout receiving GP follow-up.
2. To determine the feasibility of conducting a future randomised controlled trial to test the effectiveness of the app for patients with gout in primary care.

Participants will be asked to test the self-management app for 3 months. Data will be collected from the participants and their GPs.

Conditions

Interventions

DEVICE

Patient self-management app 'MinUrinsyregikt'

The purpose of the 'MinUrinsyregikt' -app is to support self-management for patients with gout receiving urate lowering therapy. The content of the app reflects current treatment recommendations for gout. The app includes information videos and texts about gout and gout treatment, registration tools for gout flares, serum urate levels, and medication adherence. The app enables reminder alerts for medications and for blood sampling. After the monthly blood test of serum urate levels, the patients will register this value in the app and respond to two questions to validate the serum urate blood test value. The app will then provide a date for the next blood test and advice the patient to contact their GP if the serum urate level is over the treatment target.

Sponsors & Collaborators

  • The Dam Foundation

    collaborator OTHER

  • The Norwegian Rheumatism Association

    collaborator OTHER

  • Diakonhjemmet Hospital AS

    collaborator UNKNOWN

  • REMEDY - Center for treatment of Rheumatic and Musculoskeletal Diseases

    collaborator UNKNOWN

  • Diakonhjemmet Hospital

    lead OTHER

Principal Investigators

  • Fiona Aanesen · Diakonhjemmet Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07490522 on ClinicalTrials.gov